Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,710 total articles
David M. Rubenstein, a director at Carlyle Group Inc. (NASDAQ: CG), sold 500,000 shares on March 19, 2026, for $46.68 per share, generating $23.34 million. On the same day he donated 100,000 shares to charity. The transactions leave Rubenstein with 27,399,644 directly held shares. Carlyle has announced several strategic initiatives and transactions…
Upwork Inc. Chief Accounting Officer Sabrina Mekhalfa sold 1,482 shares on March 18, 2026 to satisfy tax withholding tied to recently vested restricted stock units, while exercising options to acquire an additional 3,577 shares at no cost. The transactions were reported on a Form 4 filed with the SEC. The stock is trading near its 52-week low even …
David A. Duffield, a 10% shareholder in Workday, Inc. (WDAY), sold 104,514 Class A shares on March 18, 2026, for roughly $14.25 million and converted 107,500 Class B shares into Class A shares. The share sales took place as Workday shares have fallen 42% over six months and the company posted Q4 FY2026 results that met revenue expectations and beat…
Director Gilbert A Fuller sold 1,058 shares of USANA Health Sciences Inc (NASDAQ: USNA) on March 20, 2026, at $17.0 per share for a total of $17986, leaving him with no direct holdings. The transaction occurs as the stock trades near its 52-week low and after USANA issued updated net sales guidance for fiscal 2025 and an initial sales range for 202…
Walmart President and CEO John R. Furner sold 13,125 shares on March 19, 2026, for roughly $1.6 million under an existing Rule 10b5-1 plan. The transaction occurred at a weighted average price of $121.9595 and was carried out in multiple trades. Market commentary highlights a mix of analyst ratings and a valuation assessment that places the stock a…
Barrett Business Services Inc. director Finn Mark Steven bought 1,000 shares of the company's common stock in two purchases totaling $27,902, bringing his direct holdings to 18,943 shares. The trades occurred March 19-20, 2026, as BBSI shares linger near a 52-week low and the company reported fourth-quarter 2025 results that beat year-ago EPS and r…
Upwork Inc.'s Chief Financial Officer, Erica Gessert, completed a sale of 9,278 common shares on March 18, 2026, generating roughly $114,230. The sale occurred alongside the exercise of restricted stock units that yielded 18,132 shares. The transactions take place as the stock trades near its 52-week low, even as the company increased its share rep…
Collegium Pharmaceutical Executive Vice President and General Counsel Dieter David sold 13,976 shares on March 18, 2026, receiving about $488,099. The transaction, executed under a Rule 10b5-1 plan adopted December 5, 2025, leaves David with 77,071 shares. The company is trading around $35.50, down roughly 22% year-to-date, even as InvestingPro Fai…
Bicara Therapeutics CEO Claire Mazumdar exercised options to acquire 14,900 shares at $3.7898 and sold those 14,900 shares between March 18 and March 20, 2026 for about $282,365. The sales came after an 80% six-month rally and amid a recent $172.5 million underwritten public offering. InvestingPro flags the stock as slightly overvalued at the curre…
Mari Steinmetz, Kohl’s senior executive in charge of human resources, disclosed a March 20 sale of 1,583 shares at $12.81 worth $20,278. Filings show additional activity earlier in March including sizeable purchases and a separate disposal. The company recently reported fourth-quarter 2025 results that beat on EPS but slightly missed revenue foreca…
Equity LifeStyle Properties director David J Contis sold 3,000 shares of the company's common stock on March 18, 2026, realizing $201,659 at a weighted average price of $67.2199. On the same day, 8,000 shares held by the Contis Family Trust were disposed of as a gift. The company recently reported Q4 2025 results that beat EPS expectations but miss…
Jeffrey Housman, Chief People & Services Officer at Restaurant Brands International Inc (QSR), sold 20,000 common shares on March 20, 2026 for roughly $1.46 million and exercised options on 20,000 shares for about $1.11 million the same day. The transactions leave Housman with just over 162,076 common shares. The moves come as QSR trades near its 5…
Marketwise, Inc. (NASDAQ: MKTW) reported insider sales by Chief Financial Officer Erik Mickels totaling approximately $140,099 across two transactions on March 18 and 19, 2026. The disposals reduced Mickels' direct holdings to 85,064 shares. The sales occurred against a backdrop of solid short-term share price gains, an InvestingPro valuation asses…
Michael Moore, president of Viemed Healthcare, INC. (NASDAQ: VMD), disposed of 136,802 common shares in several transactions between March 18 and March 20, 2026, generating about $1.23 million. The sales were made indirectly through Moore Faster LLC. Viemed recently reported fourth-quarter 2025 results that beat on EPS but missed on revenue, while …
Pangaea Logistics Solutions CFO Gianni DelSignore sold 23,779 shares on March 18-19, 2026 to satisfy tax withholding from restricted stock unit vesting, generating roughly $166,215. The company recently reported fourth-quarter 2025 results that topped revenue estimates but missed on earnings per share, leaving investor reaction mixed.
David T. Bottoms, General Manager of Marketplace at Upwork Inc. (NASDAQ: UPWK), sold 18,575 shares of Upwork common stock across March 18-19, 2026, for roughly $222,957 and separately received 20,908 shares through the exercise of restricted stock units on March 18. The sales included mandated sell-to-cover transactions tied to RSU vesting and were…
Kurt M. Eckert, a director at Miami International Holdings, Inc. (MIAX), sold 37,917 shares on March 19, 2026, for $1,478,763 and exercised options to buy 12,917 shares at $12 apiece. The sale was executed under a Rule 10b5-1 trading plan adopted December 18, 2025. MIAX recently reported robust fourth-quarter 2025 financials and rising market share…
Upwork President and CEO Hayden Brown sold 23,745 shares of the company's common stock on March 18, 2026, receiving about $292,343 from those transactions, while also exercising restricted stock units that converted into 46,410 shares the same day. The stock is trading near its 52-week low, and recent corporate moves include matched-or-better-than-…
A reported insider sale at Mohawk Industries saw 6,000 shares change hands on March 19-20, 2026, totaling $581,950. The transactions occurred as the flooring manufacturer's stock hovered near its 52-week low. Mohawk recently reported Q4 2025 results that beat analyst expectations for both adjusted EPS and revenue. InvestingPro analysis cited in rep…
Lizette Benedi Herraiz, General Counsel of Strategic Education, Inc. (NASDAQ: STRA), disposed of 2,982 shares on March 18, 2026 under a Rule 10b5-1 plan, generating proceeds of $238,202. The sale, executed at a weighted average price of $79.88 and occurring within a $79.36 to $80.30 range, follows a quarter in which the company topped EPS and reven…
Ajay Madan Gopal, chief financial officer of TheRealReal, Inc. (NASDAQ: REAL), sold 51,585 shares on March 19, 2026 at $9.29 per share to satisfy withholding taxes related to a performance award. The trade, disclosed on a Form 4 filing, generated $479,224 and left the CFO with 1,179,307 shares. The company recently reported stronger-than-expected f…
Jodi Devlin, TriSalus Life Sciences' Chief of Clinical Operations, sold 3,107 shares of the company's common stock across three transactions between March 11 and March 16, 2026, for a combined $13,171. The trades occurred at prices between $4.09 and $4.13 per share. TriSalus shares are trading below those levels at $3.92 and the company is due to r…
TriSalus Life Sciences Chief Commercial Officer Richard Marshak sold 3,457 shares of the company's common stock across three transactions between March 11 and March 16, 2026, raising $14,209. The disposals were made to satisfy tax withholding obligations tied to vesting restricted stock units and are not characterized as discretionary sales. The co…
Bryan F. Cox, Chief of Research at TriSalus Life Sciences, sold 3,184 shares of the company's common stock across three transactions between March 11 and March 16, 2026, generating about $13,085. The trades were made to satisfy tax obligations tied to vesting restricted stock units and were not discretionary. Cox retains direct ownership of 163,415…
TriSalus Life Sciences Chief Regulatory Officer Jennifer Stevens sold 3,530 shares of common stock across three transactions between March 11 and March 16, 2026, to satisfy tax obligations tied to vested restricted stock units. The sales, executed at prices between $4.09 and $4.13, generated roughly $14,509 in proceeds. The filings note the sales w…
